Page 8 - Cancer Drugs

USFDA informs Biocon, Mylan of deferred action on biosimilar license plea

Biocon said its arm, Biocon Biologics, and Mylan have been informed by the USFDA of a deferred action on the biologics license application for a biosimilar to drug Avastin

Scientists find new class of drugs that may treat blood, bone marrow cancer

A group of scientists in the US, including an Indian-American from the prestigious Cleveland Clinic, have identified a potential new class of drugs that may prove effective in treating certain common types of blood and bone marrow cancers. First published in the latest edition of Blood Cancer Discovery, the decade long research which reports that a new pharmacological strategy to preferentially target and eliminate leukemia cells with TET2 mutations, was carried out by Jaroslaw Maciejewski and his collaborator Babal Kant Jha from the Cleveland Clinic Department of Translational Hematology & Oncology Research. Myeloid leukemias are cancers derived from stem and progenitor cells in the bone marrow that give rise to all normal blood cells. One of the most common mutations involved in driving myeloid leukemias are found in the TET2 gene, which has been investigated for the last decade by Maciejewski and Jha. In preclinical models, we found that a synthetic molecule called TETi76 was ..

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug

Drug major Glenmark Pharma on Tuesday said it has received tentative approval from the US health regulator for Axitinib tablets, used in the treatment of kidney cancer. The tentatively approved product is the generic version of Inlyta tablets of PF Prism CV. Glenmark Pharmaceuticals Inc, USA has received tentative approval by the United States Food & Drug Administration (USFDA) for Axitinib tablets in the strength of 1 mg and 5 mg, the company said in a regulatory filing. Quoting IQVIA sales data for the 12 months ending October 2020, Glenmark Pharma said the Inlyta Tablets, 1 mg and 5 mg market achieved annual sales of approximately USD 518.8 million. Glenmark's current portfolio consists of 166 products authorised for distribution in the US market and 45 ANDA's pending approval with the USFDA.

Natco Pharma's marketing partner gets USFDA nod for cancer treatment drug

Natco Pharma said its marketing partner Breckenridge Pharmaceutical received final approval from the USFDA for Pomalidomide Capsules, treatment of patients suffering from multiple myeloma cancer

Madras HC orders formation of panel to ensure self-reliance in cancer drugs

In its judgment the court said India can not be dependent on China for APIs and ordered the formation of a five member committee to ensure self-reliance

Top headlines: BSE-listed firms' m-cap hits new high, RBI holds key rates

From BSE-listed firms' m-cap hitting record high to Goyal getting additional charge after Paswan's death, Business Standard brings you the top headlines of the day

Gilead nears deal to buy Immunomedics for more than $20 bn: WSJ report

Gilead Sciences Inc is said to be nearing a deal to buy biopharmaceutical company Immunomedics Incfor more than $20 billion in a deal that would further expand Gilead's portfolio of cancer treatments

US FDA approves GlaxoSmithKline's experimental drug for blood cancer

Multiple myeloma is the second most common form of blood cancer in the US and is generally considered treatable, but not curable

AstraZeneca agrees to pay Japan's Daiichi $6 bn for new cancer drug

The UK drugmaker will pay Japan's Daiichi $1 billion upfront to jointly develop and bring to market a cancer therapy in early clinical tests called DS-1062, the companies said

Natco Pharma's Canadian unit, Celgene sign pact for cancer treatment drug

Lenalidomide drug is used to treat various types of cancers by slowing or stopping the growth of aberrant cells

Cancer drug with new process on slowing DNA repair shows promise in trial

The clinical trial led by investigators at the Dana-Farber Cancer Institute was detailed in the journal The Lancet Oncology

AstraZeneca plans to test new cancer medicine in coronavirus battle

The treatment for lymphoma may lessen the severity of respiratory distress by reducing the inflammation caused by the new coronavirus

WHO forecasts 81% cancer jump in poorer countries over lacking investments

The Geneva-based World Health Organization (WHO) said in a report that these countries had focused their limited resources on combating infectious diseases and improving maternal and child health

Cancer-fighting potential in nearly 50 drugs for other conditions: Study

"We found that a surprising number of non-oncology drugs are able to kill cancer cell lines in the lab," said Steven Corsello of Dana-Farber Cancer Institute

How a 31-year-old woman is spreading awareness among other cancer sufferers

Now 31, Saima Thompson is juggling a busy working life at the family restaurant, Masala Wala Cafe in Brockley, with encouraging debate about cancer in the black, Asian and minority ethnic communities

Aspirin may reduce tumour growth and lower bowel cancer risk: Study

According to the researchers, aspirin has the potential to prevent diseases that result from chronic inflammation, such as cancer, Alzheimer's, Parkinson's, and arthritis

Cancer drugs may be effective in treating chronic lung inflammation: Study

Researchers, including those from the University of Sheffield in the UK, assessed the effect of drugs used to treat different cancer types on lung damage in people living with COPD

Gene therapy to conquering hepatitis C: A decade of medical breakthroughs

Putting aside prices for a moment, it's been an exciting period for medical progress

HIVEC is next big step to prevent recurrence in superficial bladder cancer

Currently, bladder cancer in India is treated with Bacillus Calmette-Guerin (BCG) intravesical immunotherapy

Fighting Breast cancer: Follow these 7 steps apart from the treatment

This includes keeping your weight in check, being physically active, eating fruits and vegetables, avoid alcohol and cigarettes, etc